LABRA

GOAL

Validation of the positive effects of photobiomodulation (PBM) therapy for the prevention of acute radiodermatitis in breast cancer patients 

STUDY DESIGN

Placebo-controlled, randomized trial with breast cancer patients undergoing radiotherapy after a breast sparing surgery at the Ziekenhuis Oost-Limburg and Jessa Hospital (NCT03924011)  from February 2019 until present

Control group	Laser group
Standard skin care	Standard skin care
Radiotherapy (hypofractionation regimen)	Radiotherapy (hypofractionation regimen)
Placebo treatment (2x/week, from start radiotherapy)	PBM (2x/week, from start radiotherapy)

STUDY RESULTS

Study is still active and no preliminary data available 

PUBLICATIONS

Click here to edit.

PARTNERS